{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:51:43Z","timestamp":1792612303603,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jaip.2021.04.006","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T05:10:16Z","timestamp":1628140216000},"page":"2958-2966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication"],"prefix":"10.1016","volume":"9","author":[{"given":"Bernard Yu-Hor","family":"Thong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Vultaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ticha","family":"Rerkpattanapipat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.04.006_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.iac.2020.06.003","article-title":"Immune-related adverse drug reactions and immunologically mediated drug hypersensitivity","volume":"40","author":"Macy","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.04.006_bib2","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/jdv.16339","article-title":"Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)","volume":"34","author":"Kuijper","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2021.04.006_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","article-title":"SJS\/TEN 2019: from science to translation","volume":"98","author":"Chang","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2021.04.006_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000507445","article-title":"Drug-induced anaphylaxis: an update on epidemiology and risk factors","volume":"181","author":"Regateiro","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2017.06.012","article-title":"Diagnosis and management of anaphylaxis in precision medicine","volume":"140","author":"Castells","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib8","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.2196\/jmir.8206","article-title":"Clinical decision support systems for drug allergy checking: systematic review","volume":"20","author":"L\u00e9gat","year":"2018","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.jaip.2021.04.006_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1471-4906(03)00142-X","article-title":"The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation","volume":"24","author":"Rajan","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.04.006_bib11","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jaip.2017.08.004","article-title":"Rituximab hypersensitivity: evaluation, desensitization, and potential mechanisms","volume":"5","author":"Wong","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.iac.2017.07.004","article-title":"Management of hypersensitivity reactions to taxanes","volume":"37","author":"Picard","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2021.04.006_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ACI.0000000000000666","article-title":"Anaphylactic reactions to biological drugs","volume":"20","author":"Matucci","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jaip.2018.09.018","article-title":"Role of skin tests in the diagnosis of immediate hypersensitivity reactions to taxanes: results of a multicenter study","volume":"7","author":"Pagani","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/ACI.0b013e3283464bcd","article-title":"Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management","volume":"11","author":"Vultaggio","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib16","doi-asserted-by":"crossref","first-page":"eaat1479","DOI":"10.1126\/scitranslmed.aat1479","article-title":"An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis","volume":"11","author":"J\u00f6nsson","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2021.04.006_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/all.13132","article-title":"Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and\u00a0Clinical Immunology and the American Academy of Allergy, Asthma and Immunology","volume":"72","author":"Muraro","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1398-9995.2006.01058.x","article-title":"Adverse side-effects to biological agents","volume":"61","author":"Pichler","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaci.2018.02.018","article-title":"Hypersensitivity reactions to therapeutic monoclonal antibodies: phenotypes and endotypes","volume":"142","author":"Isabwe","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib20","first-page":"442","article-title":"ENDA; EAACI Interest Group on Drug Allergy. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice","volume":"21","author":"Mertes","year":"2011","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2222.1999.00453.x","article-title":"Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening","volume":"29","author":"Porri","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","article-title":"Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)","volume":"121","author":"Harper","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2021.04.006_bib23","first-page":"350","article-title":"Study of hypersensitivity reactions and anaphylaxis during anesthesia in Spain","volume":"18","author":"Lobera","year":"2008","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-6576.2007.01489.x","article-title":"Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients","volume":"52","author":"Malinovsky","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jaip.2021.04.006_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1213\/ANE.0000000000000776","article-title":"The incidence of perioperative hypersensitivity reactions: a single-center, prospective, cohort study","volume":"121","author":"Berroa","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2021.04.006_bib26","article-title":"Incidence of suspected perioperative anaphylaxis: a multicenter snapshot study","volume":"3","author":"Savic","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib27","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.jaip.2019.05.035","article-title":"Specific IgE to cefazolin: does it benefit diagnosis?","volume":"7","author":"Van Gasse","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib28","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaip.2018.01.004","article-title":"In\u00a0vitro diagnosis of immediate drug hypersensitivity during anesthesia: a review of the literature","volume":"6","author":"Ebo","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/cea.12344","article-title":"Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need","volume":"44","author":"Leysen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.anai.2015.02.002","article-title":"The utility of specific IgE testing to chlorhexidine in the investigation of perioperative adverse reactions","volume":"114","author":"Anderson","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0310057X0703500607","article-title":"The preoperative detection of risk of anaphylaxis during anaesthesia","volume":"35","author":"Fisher","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jaip.2021.04.006_bib32","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/all.13820","article-title":"An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions","volume":"74","author":"Garvey","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1399-6576.2007.01313.x","article-title":"Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia","volume":"51","author":"Kroigaard","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jaip.2021.04.006_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18176\/jiaci.0236","article-title":"Practical guidelines for perioperative hypersensitivity reactions","volume":"28","author":"Laguna","year":"2018","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bja.2018.03.004","article-title":"Safety of subsequent general anaesthesia in patients allergic to neuromuscular blocking agents: value of allergy skin testing","volume":"120","author":"Chiriac","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2021.04.006_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2014.11.011","article-title":"Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia","volume":"3","author":"Guyer","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.bja.2018.02.033","article-title":"Outcome of repeat anaesthesia after investigation for perioperative anaphylaxis","volume":"120","author":"Miller","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2021.04.006_bib39","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/cea.12743","article-title":"Dynamics of plasma levels of specific IgE in chlorhexidine allergic patients with and without accidental re-exposure","volume":"46","author":"Opstrup","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/all.12617","article-title":"Drug hypersensitivity in clonal mast cell disorders: ENDA\/EAACI position paper","volume":"70","author":"Bonadonna","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib41","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/bja\/82.5.770","article-title":"Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia","volume":"82","author":"Fisher","year":"1999","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2021.04.006_bib42","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.bja.2019.03.018","article-title":"The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status","volume":"123","author":"Garvey","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jaip.2021.04.006_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000335631","article-title":"Immediate and delayed cutaneous reactions to radiocontrast media","volume":"97","author":"Brockow","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1259\/bjr\/26301414","article-title":"Review article: acute serious and fatal reactions to contrast media: our current understanding","volume":"78","author":"Morcos","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2021.04.006_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ced.13990","article-title":"Contrast media and cutaneous reactions. Part 1. Immediate hypersensitivity reactions to contrast media and gadolinium deposition","volume":"44","author":"Tasker","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2021.04.006_bib46","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1398-9995.2008.01832.x","article-title":"Skin testing in patients with hypersensitivity reactions to iodinated contrast media\u2014a European multicenter study","volume":"64","author":"Brockow","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib47","doi-asserted-by":"crossref","first-page":"e100154","DOI":"10.1371\/journal.pone.0100154","article-title":"Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2021.04.006_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1148\/radiology.209.1.9769830","article-title":"Mechanisms of severe, immediate reactions to iodinated contrast material","volume":"209","author":"Laroche","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2021.04.006_bib49","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaip.2017.10.040","article-title":"Skin testing for suspected iodinated contrast media hypersensitivity","volume":"6","author":"Schrijvers","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaip.2019.08.001","article-title":"Validation of the prescreening intradermal skin test for predicting hypersensitivity to iodinated contrast media: a prospective study with ICM challenge","volume":"8","author":"Lee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2222.2010.03493.x","article-title":"Clinical value of negative skin tests to iodinated contrast media","volume":"40","author":"Caimmi","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib52","first-page":"183","article-title":"Skin test-positive immediate hypersensitivity reaction to iodinated contrast media: the role of controlled challenge testing","volume":"23","author":"Prieto-Garc\u00eda","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/all.12589","article-title":"Skin tests in patients with hypersensitivity reaction to iodinated contrast media: a meta-analysis","volume":"70","author":"Yoon","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib54","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaip.2017.03.026","article-title":"Drug allergy: phenotypes, endotypes, and biomarkers","volume":"5","author":"Castells","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib55","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3389\/fphar.2020.00969","article-title":"Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions","volume":"11","author":"Chang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2021.04.006_bib56","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/bcp.13294","article-title":"Pharmacogenomics of off-target adverse drug reactions","volume":"83","author":"Garon","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2021.04.006_bib57","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/all.14174","volume":"75","author":"Oussalah","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cpt.1944","article-title":"Global frequencies of clinically important HLA alleles and their implications for the cost-effectiveness of preemptive pharmacogenetic testing","volume":"109","author":"Zhou","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2021.04.006_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib60","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4168\/aair.2019.11.6.779","article-title":"Complementary participation of genetics and epigenetics in development of NSAID-exacerbated respiratory disease","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2021.04.006_bib61","doi-asserted-by":"crossref","first-page":"336","DOI":"10.18176\/jiaci.0199","article-title":"Update on the genetic basis of drug hypersensitivity reactions","volume":"27","author":"Jurado-Escobar","year":"2017","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"20","key":"10.1016\/j.jaip.2021.04.006_bib62","first-page":"31405","article-title":"Beta-lactam-induced immediate hypersensitivity reactions: a genome-wide association study of a deeply phenotyped cohort","volume":"S0091-6749","author":"Nicoletti","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib63","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1177\/1078155218811505","article-title":"Cetirizine versus diphenhydramine in the prevention of chemotherapy-related hypersensitivity reactions","volume":"25","author":"Durham","year":"2019","journal-title":"J\u00a0Oncol Pharm Pract"},{"issue":"suppl","key":"10.1016\/j.jaip.2021.04.006_bib64","article-title":"Infusion-related reactions (IRR) associated with cetuximab plus irinotecan treatment in patients with irinotecan-resistant metastatic colorectal cancer (mCRC): findings from the MABEL study","volume":"2518","author":"Siena","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2021.04.006_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.04.006_bib66","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/ard.2005.037499","article-title":"Study of the tolerance of infliximab infusions with or without betamethasone premedication in patients with active rheumatoid arthritis","volume":"64","author":"Sany","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2021.04.006_bib67","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/039463200802100214","article-title":"Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience","volume":"21","author":"Vultaggio","year":"2008","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2021.04.006_bib68","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1188\/10.CJON.E10-E21","article-title":"Infusion reactions: diagnosis, assessment, and management","volume":"14","author":"Vogel","year":"2010","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jaip.2021.04.006_bib69","doi-asserted-by":"crossref","first-page":"804A","DOI":"10.1182\/blood.V108.11.2841.2841","article-title":"A\u00a0Phase II study of the TNF-a inhibitor etanercept and thrice weekly rituximab in relapsed CLL\/SLL: clinical activity in the absence of del(17p13) genomic abnormalities","volume":"108","author":"Lin","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2021.04.006_bib70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-199601270-00011","article-title":"Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome","volume":"61","author":"Eason","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jaip.2021.04.006_bib71","first-page":"2019","article-title":"Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction","volume":"23","author":"Berger","year":"2015","journal-title":"Support Care Cancer"},{"issue":"suppl","key":"10.1016\/j.jaip.2021.04.006_bib72","article-title":"Cetuximab use without chronic antihistamine premedication","volume":"24","author":"Timoney","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2021.04.006_bib73","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1200\/JCO.2000.18.1.102","article-title":"Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center","volume":"18","author":"Markman","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2021.04.006_bib74","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in\u00a0vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaip.2021.04.006_bib75","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejps.2011.09.016","article-title":"Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20","volume":"45","author":"Weiszh\u00e1r","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jaip.2021.04.006_bib76","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","article-title":"Hypersensitivity reactions from taxol","volume":"8","author":"Weiss","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2021.04.006_bib77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2044.2008.05733.x","article-title":"Working Party of the Association of Anaesthetists of Great Britain and Ireland. Suspected anaphylactic reactions associated with anaesthesia","volume":"64","author":"Harper","year":"2009","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaip.2021.04.006_bib78","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1213\/00000539-199303000-00037","article-title":"Latex allergy: failure of prophylaxis to prevent severe reaction","volume":"76","author":"Setlock","year":"1993","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaip.2021.04.006_bib79","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/pan.12305","article-title":"Effects of promethazine or dexamethasone pretreatment on mivacurium-induced histamine release in children","volume":"24","author":"Xiang","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jaip.2021.04.006_bib80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.anai.2018.05.004","article-title":"Efficacy of a single dose of omalizumab for the prevention of ethylene oxide intraoperative anaphylaxis","volume":"121","author":"Bil\u00f2","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib81","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1259\/0007-1285-56-669-647","article-title":"The release of histamine from human basophils by radiological contrast agents","volume":"56","author":"Assem","year":"1983","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2021.04.006_bib82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1259\/bjr.71.841.9534695","article-title":"Effect of radiographic contrast media on histamine release from human mast cells and basophils","volume":"71","author":"Peachell","year":"1998","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jaip.2021.04.006_bib83","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0091-6749(96)80162-X","article-title":"Human basophil\/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release","volume":"97","author":"Stellato","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fendo.2017.00016","article-title":"New insights in glucocorticoid receptor signaling\u2014more than just a ligand-binding receptor","volume":"8","author":"Scheschowitsch","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jaip.2021.04.006_bib85","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s40521-019-00224-z","article-title":"Premedication for iodinated contrast media induced immediate hypersensitivity reactions","volume":"6","author":"Schrijvers","year":"2019","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1148\/radiology.184.2.1620832","article-title":"Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media","volume":"184","author":"Bertrand","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2021.04.006_bib87","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2214\/ajr.162.3.8109489","article-title":"Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media","volume":"162","author":"Lasser","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2021.04.006_bib88","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bmj.38905.634132.AE","article-title":"Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review","volume":"333","author":"Tram\u00e8r","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.04.006_bib89","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/all.14656","article-title":"Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity","volume":"76","author":"Torres","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib91","series-title":"ACR Manual","year":"2021"},{"key":"10.1016\/j.jaip.2021.04.006_bib92","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2214\/AJR.14.13810","article-title":"Rates of breakthrough reactions in inpatients at high risk receiving premedication before contrast-enhanced CT","volume":"205","author":"Mervak","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2021.04.006_bib93","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2021.04.006_bib94","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1148\/radiol.2015151143","article-title":"Indirect cost and harm attributable to oral 13-hour inpatient corticosteroid prophylaxis before contrast-enhanced CT","volume":"279","author":"Davenport","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2021.04.006_bib95","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1007\/s00330-015-4028-1","article-title":"Protective effect against repeat adverse reactions to iodinated contrast medium: premedication vs. changing the contrast medium","volume":"26","author":"Abe","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jaip.2021.04.006_bib96","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1007\/s00330-016-4682-y","article-title":"Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: a multicentre retrospective cohort study","volume":"27","author":"Park","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jaip.2021.04.006_bib97","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.jaip.2019.04.036","article-title":"Novel strategy for the prevention of recurrent hypersensitivity reactions to radiocontrast media based on skin testing","volume":"7","author":"Kwon","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1148\/radiol.2020192855","article-title":"Breakthrough hypersensitivity reactions to gadolinium-based contrast agents and strategies to decrease subsequent reaction rates: a systematic review and meta-analysis","volume":"296","author":"Walker","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2021.04.006_bib99","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/RLI.0000000000000750","article-title":"Empiric switching of gadolinium-based contrast agents in patients with history of previous immediate hypersensitivity reaction to GBCA: a prospective single-center, single-arm efficacy trial","volume":"56","author":"Walker","year":"2021","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jaip.2021.04.006_bib100","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jaip.2020.11.023","article-title":"Hypersensitivity to gadolinium-based contrast agents: a single-center retrospective analysis over 7 years","volume":"9","author":"Mankouri","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib101","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.anai.2017.07.022","article-title":"Management around invasive procedures in mastocytosis: an update","volume":"119","author":"Hermans","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib102","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000366204","article-title":"Risk factors in fatal cases of anaphylaxis due to contrast media: a forensic evaluation","volume":"164","author":"Palmiere","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib103","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity\u2014a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib104","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00262-012-1273-x","article-title":"Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization","volume":"61","author":"Castells","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaip.2021.04.006_bib105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib106","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jaip.2018.07.031","article-title":"A\u00a0large single-hospital experience using drug provocation testing and rapid drug desensitization in hypersensitivity to antineoplastic and biological agents","volume":"7","author":"Madrigal-Burgaleta","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.04.006_bib107","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/eji.201040810","article-title":"Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting Fc\u03b5RI internalization","volume":"41","author":"Sancho-Serra Mdel","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib108","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/14740330903446936","article-title":"Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity","volume":"9","author":"Limsuwan","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaip.2021.04.006_bib109","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12016-014-8416-0","article-title":"Re-visiting hypersensitivity reactions to taxanes: a comprehensive review","volume":"49","author":"Picard","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0091-6749(96)70281-6","article-title":"Successful parenteral desensitization to paclitaxel","volume":"97","author":"Essayan","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib111","first-page":"170","article-title":"Immunoglobulin E-mediated severe anaphylaxis to paclitaxel","volume":"20","author":"Prieto Garc\u00eda","year":"2010","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib112","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/all.12105","article-title":"Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment","volume":"68","author":"Madrigal-Burgaleta","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib113","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2015.10.039","article-title":"Risk stratification and skin testing to guide re-exposure in taxane-induced hypersensitivity reactions","volume":"137","author":"Picard","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib114","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/all.12620","article-title":"Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization","volume":"70","author":"Alvarez-Cuesta","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.04.006_bib115","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1081-1206(10)60247-5","article-title":"Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization","volume":"102","author":"Breslow","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.04.006_bib116","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaip.2017.11.013","article-title":"Assessment of antihistamines and corticosteroids as premedication in rapid drug desensitization to paclitaxel: outcomes in 155 procedures","volume":"6","author":"Lopez-Gonzalez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821004426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821004426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:28:45Z","timestamp":1761974925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821004426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":115,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2213219821004426"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.04.006","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}